Nadejda Sapojnic

Nadejda Sapojnic

Cardiologist, Doctor of Medical Sciences

  • Author of 54 scientific papers published in specialized journals, oral communications at national and international conferences, of which 22 were presented at international conferences and published in international journals with IF.
  • Publications:

    • „Boala mitrală mixomatoasă: în căutarea unor soluții noi”. Buletinul Academiei de Științe a Moldovei. Științe medicale Nr.1 (58)/2018, p.147-152. ISSN 1857-0011.
    • „Efectele pleiotrope a denervării arterelor renale în hipertensiunea arterială rezistentă la tratament“. Buletinul Academiei de Științe a Moldovei. Științe medicale Nr.1 (58)/2018, p.163-167. ISSN 1857-0011.
    • “Efficacy of eprosartan and ramipril on blood pressure variability, LV remodeling and insulin resistance in essential hypertension” Journal of Hypertension Vol.36 (2018): Suppl 1; p-269-270.
    • “Efficacy of long lasting therapy with ramipril and eprosartan on diastolic dysfunction, functional class of HFpEF and insulin resistance in hypertensives”. European Journal of Preventive Cardiology, Vol 25 (2018); Suppl.2, p72-73.
    • “The correlation between endothelial dysfunction and the treatment with nebivolol in patients with diabetes and angina pectoris undergoing coronary angioplasty”. Atherosclerosis, Vol. 275 (2018), p. e118. P1.3.050. DOI: https://doi.org/10.1016/j.atherosclerosis.2018.06.336.
    • “Rolul imagisticii prin rezonanță magnetică în patologia cardiovasculară”. Buletin Academiei de Științe a Moldovei, 2019, p 125-131.
    • “Terapii interventionale noi in hipertensiunea arteriala rezistenta la tratament”. Buletin Academiei de Științe a Moldovei, 2019, p 93-96.
    • “The effects of renal artery denervation on blood pressure values and diastolic dysfunction in resistant hypertension.” European Journal of Preventive Cardiology, 2019, 26 (1), 757-758. ISSN: 2047-4873. (IF: 5,64).
    • “Evolution of LV remodeling geometry and insulin resistance indices under conventional active medication on RAS: ramipril and eprosartan”. European Journal of Heart Failure, 2019, 21 (1), 202-203. ISSN:1879-0844. (IF: 13,965).
    • “Influence of long-term therapy with Losartan, Valsartan and Eprosartan on left ventricular hypertrophy and NT- pro BNP level in hypertensives”. Journal of Hypertension, 2019, 37 (1), 172-173. ISSN: ISSN 0263-6352. (IF: 4.092).
    • “Efectul antihipertensiv al desimpatizării arterelor renale versus tratament farmacologic la pacienții cu hipertensiune arterială rezistentă”. In: Buletinul Academiei de Științe a Moldovei. Științe medicale. 2020, vol.1(65), pp. 223-227. ISSN: 1857-0011 (Categoria B).
    • “Remodelarea cardiacă în HTA rezistentă – impactul tratamentului farmacologic versus invaziv”. In: Buletinul Academiei de Științe a Moldovei. Științe medicale. 2020, vol.1(65), pp. 231-239. ISSN: 1857-0011 (Categoria B).
    • “Determinanțele genetice și soluții personalizate în managementul hipertensiunii arteriale esențiale.” In: Buletinul Academiei de Științe a Moldovei. Științe medicale. 2020, vol.1(65), pp. 122-128. ISSN: 1857-0011 (Categoria B).
    • “COVID-19 și sistemul cardiovascular: concepte și viziuni actuale.” In: Buletinul Academiei de Științe a Moldovei. Științe medicale. 2020, vol.1(65), pp. 9-48. ISSN: 1857-0011 (Categoria B).
    • “Evolution of vascular elasticity indices under conventional active RASS medication: ramipril vs eprosartan”. In: European Journal of Preventive Cardiology. EAPC Essentials Abstract Supplement. 2020, vol. 27(1)_suppl., p. S25. ISSN: 2047-4873.
    • “The influence of renal denervation treatment on blood pressure in patients with resistant hypertension.” In: European Journal of Preventive Cardiology. EAPC Essentials Abstract Supplement. 2020, vol. 27 (1) _suppl., pp. S26 – S27. ISSN: 2047-4873.
    • “Arterial stiffness and diastolic function alteration in essential hypertension.“ In: European Journal of Heart Failure. 2020, vol. 22 (Suppl.S1), p.191. ISSN: 1879-0844.
    • “Indicele HOMAIR ca predictor al severității alterărilor geometriei ventriculare stângi în hipertensiunea arterială esențială și insulinorezistență.“ In: Romanian Journal of Cardiology. 2020, vol. 30 (Suppl.), pp. 102 – 103. ISSN: 1583-2996. ISSN: 1583-2996 (Categoria B+).
    • “Sympathetic renal denervation treatment in resistant hypertension: one-year follow-up.“ In: European Heart Journal. 2020 (preprint). ISSN: 0195-668X.

    Education and training:

    2019Speaker within the project “New aspects in the treatment of the hypertensive patient with ICP”, Chisinau, Moldova

    2018Speaker within the project “Can we prevent cardiovascular death and the risk of fatal cardio/cerebrovascular events due to hypertension? How?” Chisinau, Moldova

    11-12 December 2018Heart Failure Perceptorship, at the University Hospital Center of Zagreb, Dept. of Cardiovascular Diseases, Zagreb, Croatia

    2017-presentSenior scientific researcher, Hypertension Department of the Institute of Cardiology, Chisinau, Moldova

    11-17 October 2015AAF / IMO / Sazburg Well Cornell Seminar in Cardiology, Salzburg, Austria

    01-25 May 2012General Hospital of Salzburg, Department of Cardiology, Salzburg, Austria (observership)

    1-09 September 2007Cardiovascular Interventional Treatment Course (CITC), Gaziantep, Turkey (internship)

    September-November 2006Internship in Echocardiography within the Functional Diagnosis Department, and 29.01-16.02.2018 within the Imaging Department of the Institute of Cardiology, N. Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova

    2004-2006Postgraduate studies through residency in cardiology, within the Institute of Cardiology, Chisinau, Moldova

    2001-2004Postgraduate studies through residency in internal medicine, N. Testemitanu State University of Medicine and Pharmacy, Institute of Cardiology (Diploma – AL no. 001220)

    1995-2001N. Testemitanu State University of Medicine and Pharmacy, General Medicine Department (Diploma – AS no. 0011265)

    0

    We use cookies to improve your experience. By continuing to browse, you agree to our use of cookies. Learn more